Mechanisms through which bradykinin promotes glomerular injury in diabetes

American Journal of Physiology - Renal Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Tan, Yan ^a   Wang, Bing ^a   Keum, Joo Seob ^a   Jaffa, Ayad A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Connective tissue growth factor; Diabetic nephropathy; Glomerulosclerosis

Indexed keywords

BETA ACTIN; BRADYKININ; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; KALLIKREIN KININ SYSTEM; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY VASCULAR RESISTANCE; MALE; MESANGIUM CELL; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

EID: 14044255919     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00165.2004     Document Type: Article

References (40)

1. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327: 125-130, 1993.
2. Bradham DM, Igarashi A, Potter RL, and Grotendorst GR. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294, 1991.
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
4. Christopher J and Jaffa AA. Diabetes modulates the expression of glomerular kinin receptors. Int Immunopharmacol 2: 1771-1779, 2002.
5. Chung KY, Agarwal A, Uitto J, and Mauviel A. An AP-1 binding sequence is essential for regulation of the human α2 (I) collagen (COL1A2) promoter activity by transforming growth factor-β. J Biol Chem 271: 3272-3278, 1996.
6. DeRubertis FR and Craven PA. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms of potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43: 1-8, 1994.
7. Drummond K and Mauer M, for the International Diabetic Nephropathy Study Group. The early natural history of nephropathy in type 1 diabetes: early renal structural changes in type 1 diabetes. Diabetes 51: 1580-1587, 2002.
8. Duncan MR, Frazier KS, Abramson S, Williams S, Kalpper H, Huang X, and Grotendorst GR. Connective tissue growth factor mediates transforming growth factor-β-induced collagen synthesis: downregulation by cAMP. FASEB J 13: 1774-1786, 1999.
9. El-Dahr SS, Dipp S, and Baricos WH. Bradykinin stimulates the ERK-ELK-1-Fos/AP-1 pathway in mesangial cells. Am J Physiol Renal Physiol 275: F343-F352, 1998.
10. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-Martin D, Greene EL, Grorendorst G, and Trojanowska M. TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 283: F707-F716, 2002.
11. Greene EL, Velarde V, and Jaffa AA. Role of reactive oxygen species in bradykinin-induced mitogen activated protein kinase and c-fos induction in vascular cells. Hypertension 35: 942-947, 2000.
12. Grotendorst GR, Okochi H, and Hayashi N. A novel transforming growth factor-β response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7: 469-480, 1996.
13. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, and Kikkawa R. MAPK cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46: 847-853, 1997.
14. Harvey JN, Edmundson AW, Jaffa AA, Martin LL, and Mayfield RK. Renal kallikrein excretion of kallikrein and eicosanoids in patients with type 1 diabetes: relationship to glomerular and tubular function. Diabetologia 35: 857-862, 1992.
15. Harvey JN, Jaffa AA, Margolius HS, and Mayfield RK. Renal kallikrein and the hemodynamic abnormalities of the diabetic kidney. Diabetes 39: 299-304, 1990.
16. Isono M, Cruz C, Chen S, Hong S, and Ziyadeh FN. Extracellular signal-regulated kinase mediates stimulation of TGF-β and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11: 2222-2230, 2000.
17. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, and Goldschmeding R. Expression of connective tissue growth factor in renal fibrosis. Kidney Int 53: 853-861, 1998.
18. Jaffa AA, Chai KX, Chao J, Chao L, and Mayfield RK. Effects of diabetes and insulin on expression of kallikrein and rennin genes in the kidney. Kidney Int 47: 789-795, 1992.
19. Jaffa AA, Miller DH, Bailey GS, Chao J, Margolius HS, and Mayfield RK. Abnormal regulation of renal kallikrein in experimental diabetes: effects of insulin on prokallikrein synthesis and activation. J Clin Invest 80: 1651-1659, 1987.
20. Jaffa AA, Miller BS, Rosenzweig SA, Naidu PS, Velarde V, and Mayfield RK. Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol Renal Physiol 273: F916-F924, 1997.
21. Jaffa AA, Rust PF, and Mayfield RK. Kinin: a mediator of diabetes-induced glomerular hyperfiltration. Diabetes 44: 156-160, 1995.
22. Jaffa AA, Vio CP, Velarde V, LeRoith D, and Mayfiled RK. Renal kallikrein and renin mRNA levels in diabetes and their induction by insulin and insulin-like growth factor I. Diabetes 46: 2040-2056, 1997.
23. Kim S, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, and Roberts AB. Autoinduction of transforming growth factor-β is mediated by the AP-1 complex. Mol Cell Biol 10: 1492-1497, 1990.
24. Klahr S, Schreiner G, and Ichikawa I. The progression of renal disease. N Engl J Med 318: 1657-1666, 1988.
25. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, and King GL. Characterization of PKCβ isoform activation on gene expression of transforming growth factor-β, extracellular matrix components and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100: 115-126, 1997.
26. Lovett DH, Sterzel RB, Kashgarian M, and Ryan JL: Proteinase activity produced in vitro by cells of glomerular mesangium. Kidney Int 23: 342-349, 1983.
27. Lowry OH, Rosenbrough NJ, Faee AL, and Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1957.
28. Lutterel LM, Hawes BE, Biesen TV, Lutterel DK, Lansing TJ, and Lefkowitz RJ. Role of c-src tyrosine kinases in G protein-coupled receptor Gβγ subunit-mediated activation of mitogen activated protein kinases. J Biol Chem 271: 19443-19450, 1996.
29. Mauer M and Drummond K, for the International Diabetic Nephropathy Study Group. The early natural history of nephropathy in type 1 diabetes: study design and baseline characteristics of the study participants. Diabetes 51: 1572-1579, 2000.
30. Murphy M, Godson C, Cannon S, Kato S, Machenzie HS, Martin F, and Brady HR. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274: 5830-5834, 1999.
31. Riser BL, Denichilo M, Cortes P, Baker C, Grondin JM, Yee J, and Narins RG. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol 11: 25-38, 2000.
32. Schaeffer HJ and Weber MJ. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19: 2435-2444, 1999.
33. Sharma K and Ziyadeh FN. The emerging role of transforming growth factor-β in kidney disease. Am J Physiol Renal Fluid Electrolyte Physiol 266: F829-F842, 1994.
34. The Diabetes Control and Complications Research Study Group. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47: 1703-1720, 1995.
35. Tschope CA, Reinecke A, Seidl U, Yu M, Gavriluk V, Riester U, Gohlke P, Graf K, Bader M, Hilgenfeldt U, Pesquero JB, Ritz E, and Unger T. Functional, biochemical and molecular investigations of renal kallikrein-kinin system in diabetic rats. Am J Physiol Heart Circ Physiol 277: H2333-H2340, 1999.
36. United States Renal Data System. 2000 Annual Data Report. Bethesda, MD: National Institutes of Health, 2000.
37. Velarde V, Ullian ME, Morinelli TA, Mayfield RK, and Jaffa AA. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol Cell Physiol 277: C253-C261, 1999.
38. Vora JP, Oyama TT, Thompson MM, and Anderson S. Interactions of the kallikrein-kinin system and renin-angiotensin systems in experimental diabetes. Diabetes 46: 107-112, 1997.
39. 1-integrin in human mesangial cells. J Am Soc Nephrol 14: 601-610, 2003.
40. Wolf G and Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999.